Item:Q21545: Difference between revisions

← Older edit

@@ Property / subclass of @@
+Insulin/IGF/Relaxin family
@@ Property / subclass of: Insulin/IGF/Relaxin family / rank @@
+Normal rank
@@ Property / chemical formula @@
+C₂₆₇H₄₀₄N₇₂O₇₈S₆
@@ Property / chemical formula: C₂₆₇H₄₀₄N₇₂O₇₈S₆ / rank @@
+Normal rank
@@ Property / medical condition treated @@
+maturity-onset diabetes of the young type 2
+Normal rank
@@ Property / medical condition treated @@
+type-1 diabetes
@@ Property / medical condition treated: type-1 diabetes / rank @@
+Normal rank
@@ Property / medical condition treated @@
+hyperglycemia
@@ Property / medical condition treated: hyperglycemia / rank @@
+Normal rank
@@ Property / medical condition treated @@
+type-1 diabetes
@@ Property / medical condition treated: type-1 diabetes / rank @@
+Normal rank
@@ Property / medical condition treated: type-1 diabetes / qualifier @@
+start time: 19 April 2000Timestamp +2000-04-19T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2000-04-19T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / medical condition treated: type-1 diabetes / qualifier @@
+approved by: Food and Drug Administration
@@ Property / subject has role @@
+anti-diabetic medication
@@ Property / subject has role: anti-diabetic medication / rank @@
+Normal rank
@@ Property / related image @@
+Toujeo 300 IU-ml inj.jpg
@@ Property / related image: Toujeo 300 IU-ml inj.jpg / rank @@
+Normal rank
@@ links / en / name / links / en / name @@
+Insulin glargine